Search - tctmd.com

Displaying 261 - 280 of 337

Sort: Relevancy | Date

Presentation TCT 2015

After 2 Failed RCTs: Root-Cause Analysis, Unmet Technical Needs and Opportunities for the Development of Next-Generation DCBs, and Studies

Presenter: Gary M. Ansel, J. A. Mustapha

October 12, 2015

Presentation TCT 2015

DCB in BTK Intervention: Summary of the Evidence From 2 Failed RCTs IN.PACT DEEP and BIOLUX P-II

Presenter: Gary M. Ansel, J. A. Mustapha

October 12, 2015

Presentation TCT 2015

BTK Disease: Impact of Disease Complexity on Technical Approach and Clinical Outcomes Are DCBs the Right Answer?

Presenter: Gary M. Ansel, J. A. Mustapha, Peter A. Schneider

October 12, 2015

Presentation TCT 2015

Restenosis Patterns After DCB and Management Strategies

Presenter: Krishna J. Rocha-Singh, Andrej Schmidt, Gunnar Tepe

October 12, 2015

Presentation TCT 2015

Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies

Presenter: Krishna J. Rocha-Singh, Andrej Schmidt, Lawrence A. Garcia

October 12, 2015

Presentation TCT 2015

DCB With or Without Atherectomy in CFA Lesions vs Surgery: Rationale and Design of the PESTO-CFA Trial

Presenter: Krishna J. Rocha-Singh, Andrej Schmidt, Aljoscha Rastan

October 12, 2015

Presentation TCT 2015

Spot Stenting and DCB Use: Rationale and Therapeutic Options

Presenter: Krishna J. Rocha-Singh, Andrej Schmidt, Peter A. Schneider

October 12, 2015

Presentation TCT 2015

DCBs Plus Adjunctive BMS Use: Current Use, Rationale, and Pitfalls

Presenter: Krishna J. Rocha-Singh, Andrej Schmidt

October 12, 2015

Presentation TCT 2015

Next-Generation DCBs: Alternative Coatings and Drug-Delivery Platforms for SFA Intervention

Presenter: Krishna J. Rocha-Singh, Andrej Schmidt, Juan F. Granada

October 12, 2015

Presentation TCT 2015

12 Month Outcomes From the Lutonix Global SFA Real-World Registry

Presenter: John R. Laird Jr, Gunnar Tepe, Marcus Thieme

October 12, 2015

Presentation TCT 2015

The IN.PACT Global Registry: One-Year Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

Presenter: John R. Laird Jr, Gunnar Tepe, Gary M. Ansel

October 12, 2015

Presentation TCT 2015

DCB for Long and Highly Calcified Vessels: Is Upfront Vessel Preparation a Rational Choice?

Presenter: John R. Laird Jr, Gunnar Tepe

October 12, 2015

Presentation TCT 2015

DCB Treatment of In-Stent Restenosis With or Without Upfront Debulking: Updated Results

Presenter: John R. Laird Jr, Gunnar Tepe, Thomas Zeller

October 12, 2015

Presentation TCT 2015

The ILLUMINATE RCT: One-Year Outcomes

Presenter: William A. Gray, Peter A. Schneider, Mahmood K. Razavi

October 12, 2015

Presentation TCT 2015

Extended Follow-up From LEVANT 2: Two-Year Follow-up and Subgroup Analyses

Presenter: William A. Gray, Peter A. Schneider, Andrej Schmidt

October 12, 2015

Presentation TCT 2015

IN.PACT SFA 1-year Outcomes: Subgroup Analyses

Presenter: William A. Gray, Peter A. Schneider, John R. Laird Jr

October 12, 2015

Presentation TCT 2015

Optimizing Outcomes With DCB: Tips and Tricks

Presenter: Greg L. Kaluza, Thomas Zeller

October 12, 2015

Presentation TCT 2015

FIH Data Review Regarding Degree and Duration of DCB Efficacy in De Novo Lesions: Is There a Class Effect?

Presenter: Greg L. Kaluza, Thomas Zeller, Gunnar Tepe

October 12, 2015

Presentation TCT 2015

Technical Overview of FDA-Approved and CE-Marked DCB Technologies for PVD Intervention

Presenter: Greg L. Kaluza, Thomas Zeller

October 12, 2015

Presentation ISET 2015

Drug-Coated Balloons: How Does It Change the Treatment Landscape for CLI?

Presenter: Thomas Zeller

February 03, 2015

Advertisement

After 2 Failed RCTs: Root-Cause Analysis, Unmet Technical Needs and Opportunities for the Development of Next-Generation DCBs, and Studies

DCB in BTK Intervention: Summary of the Evidence From 2 Failed RCTs IN.PACT DEEP and BIOLUX P-II

BTK Disease: Impact of Disease Complexity on Technical Approach and Clinical Outcomes Are DCBs the Right Answer?

Restenosis Patterns After DCB and Management Strategies

Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies

DCB With or Without Atherectomy in CFA Lesions vs Surgery: Rationale and Design of the PESTO-CFA Trial

Spot Stenting and DCB Use: Rationale and Therapeutic Options

DCBs Plus Adjunctive BMS Use: Current Use, Rationale, and Pitfalls

Next-Generation DCBs: Alternative Coatings and Drug-Delivery Platforms for SFA Intervention

12 Month Outcomes From the Lutonix Global SFA Real-World Registry

The IN.PACT Global Registry: One-Year Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

DCB for Long and Highly Calcified Vessels: Is Upfront Vessel Preparation a Rational Choice?

DCB Treatment of In-Stent Restenosis With or Without Upfront Debulking: Updated Results

The ILLUMINATE RCT: One-Year Outcomes

Extended Follow-up From LEVANT 2: Two-Year Follow-up and Subgroup Analyses

IN.PACT SFA 1-year Outcomes: Subgroup Analyses

Optimizing Outcomes With DCB: Tips and Tricks

FIH Data Review Regarding Degree and Duration of DCB Efficacy in De Novo Lesions: Is There a Class Effect?

Technical Overview of FDA-Approved and CE-Marked DCB Technologies for PVD Intervention

Drug-Coated Balloons: How Does It Change the Treatment Landscape for CLI?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content